There's a heated debate over the investigational treatment called NurOwn.
of some of the health programs expiring after Sept. 30, such as funding for community health centers, the National Health Service Corps and the special diabetes programs, while averting a cut to safety-net hospitals’ Medicaid payments.The Senate deal, which would fund the government for six additional weeks, cleared its first procedural hurdle in a 77-19 vote.
will convene a meeting of his science and technology advisers to discuss ways to strengthen patient safety through the delivery of high-quality health care, among other priorities, according to a White House official. Advanced Research Projects Agency for Healthto combat infections and address the growing threat of antibiotic-resistant bacteria. The Ohio Supreme Court is slated to hear oral arguments in a case that centers on the state’s abortion ban.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA to Review Experimental ALS Treatment This WeekThe Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig's disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease. Those advocates still face one giant hurdle: FDA...
Read more »
FDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Read more »
FDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Read more »
FDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease
Read more »
FDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Read more »
FDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Read more »